- Home
- MAGH vs BRNS Comparison
MAGH vs BRNS Comparison
Compare MAGH & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAGH
- BRNS
- Stock Information
- Founded
- MAGH 2012
- BRNS 2016
- Country
- MAGH Singapore
- BRNS United Kingdom
- Employees
- MAGH N/A
- BRNS N/A
- Industry
- MAGH Engineering & Construction
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MAGH Industrials
- BRNS Health Care
- Exchange
- MAGH Nasdaq
- BRNS Nasdaq
- Market Cap
- MAGH 51.8M
- BRNS 48.3M
- IPO Year
- MAGH 2025
- BRNS 2021
- Fundamental
- Price
- MAGH $1.11
- BRNS $1.22
- Analyst Decision
- MAGH
- BRNS Strong Buy
- Analyst Count
- MAGH 0
- BRNS 1
- Target Price
- MAGH N/A
- BRNS $3.00
- AVG Volume (30 Days)
- MAGH 648.0K
- BRNS 25.3K
- Earning Date
- MAGH 01-01-0001
- BRNS 11-05-2025
- Dividend Yield
- MAGH N/A
- BRNS N/A
- EPS Growth
- MAGH N/A
- BRNS N/A
- EPS
- MAGH 0.03
- BRNS N/A
- Revenue
- MAGH $13,529,576.00
- BRNS $14,969,000.00
- Revenue This Year
- MAGH N/A
- BRNS N/A
- Revenue Next Year
- MAGH N/A
- BRNS N/A
- P/E Ratio
- MAGH $35.69
- BRNS N/A
- Revenue Growth
- MAGH 10.71
- BRNS 1766.46
- 52 Week Low
- MAGH $0.99
- BRNS $0.64
- 52 Week High
- MAGH $5.15
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- MAGH N/A
- BRNS 48.81
- Support Level
- MAGH N/A
- BRNS $1.11
- Resistance Level
- MAGH N/A
- BRNS $1.35
- Average True Range (ATR)
- MAGH 0.00
- BRNS 0.10
- MACD
- MAGH 0.00
- BRNS 0.01
- Stochastic Oscillator
- MAGH 0.00
- BRNS 55.17
About MAGH Magnitude International Ltd Ordinary Shares
Magnitude International Ltd is providing electrical installation services to customers in both the private and public sectors in Singapore. It includes the planning, design, material selection, installation, testing, commissioning and certification of the electrical equipment/systems to be installed. The Group's revenue is derived from Singapore.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.